The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo. (Q50510432)
Jump to navigation
Jump to search
scientific article published in October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo. |
scientific article published in October 2011 |
Statements
The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo. (English)
1 reference
1 reference
Emelie A Djerf Severinsson
1 reference
Cecilia Trinks
1 reference
Avni Abdiu
1 reference
Anna-Lotta Hallbeck
1 reference
Olle Stål
1 reference
Thomas M Walz
1 reference
1 October 2011
1 reference
414
1 reference
3
1 reference
563-568
1 reference